E04.936

5 trials

Sponsors

Paulo Roberto Slud Brofman, Universidade Federal de São Paulo - Unifesp, Universidade Federal de Ciências da Saúde de Porto Alegre, Hospital de Clínicas da Universidade Federal do Paraná - HCUFPR, Pontifícia Universidade Católica do Paraná

Conditions

COVID-19-associated acute respiratory distress syndromeCoronavirus infectionGraft vs Host DiseaseKeloidRenal insufficiency

Phase 2

Use of mesenchymal stromal cells for Graft-versus-host disease after stem cell transplantation

Active, not recruitingRBR-7s99ksf

Hospital de Clínicas da Universidade Federal do Paraná - HCUFPRGraft vs Host Disease

Start: 2015-04-27Updated: 2025-10-27

Unknown Phase

Training of Breathing Muscles in children after renal Transplantation

RecruitingRBR-7pyznv

Universidade Federal de Ciências da Saúde de Porto AlegreRenal insufficiency

Start: 2017-08-22Updated: 2025-10-27

Use of mesenchymal cells for the treatment of patients with respiratory syndrome caused by new coronavirus

Active, not recruitingRBR-3fz9yr

Paulo Roberto Slud BrofmanCOVID-19-associated acute respiratory distress syndrome

Start: 2020-06-10Updated: 2025-10-27

Mesenchymal stromal cells for the treatment of patients with SARS-CoV-2 pneumonia

Pontifícia Universidade Católica do ParanáCoronavirus infection

Start: 2021-08-26Updated: 2025-10-27

The use of Fat Grafting in the Treatment of Keloid: Randomized Clinical Trial

RecruitingRBR-5ry9tn5

Universidade Federal de São Paulo - UnifespKeloid

Start: 2023-06-08Updated: 2025-10-27

Related Papers

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.

2022-03-2136 citations